Synergistic Interaction of Hypertension and Diabetes in Promoting Kidney Injury and the Role of Endoplasmic Reticulum Stress

Hypertension

Volumn 69, Issue 5, 2017, Pages 879-891

  Wang, Zhen ^a,b   Do Carmo, Jussara M ^a,b   Aberdein, Nicola ^a,b   Zhou, Xinchun ^a   Williams, Jan M ^a   Da Silva, Alexandre A ^c   Hall, John E ^a,b  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^c Barao de Maua University   (Brazil)

Author keywords

blood pressure; glomerular filtration rate; kidney disease; oxidative stress; tauroursodeoxycholic acid; type 2 diabetes mellitus

Indexed keywords

4 HYDROXYNONENAL; ALBUMIN; GLUCOSE; INSULIN; LEPTIN; PROTEIN; TAUROURSODEOXYCHOLIC ACID; GLUCOSE BLOOD LEVEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTHROPOMETRY; AORTA CONSTRICTION; ARTICLE; BLOOD BIOCHEMISTRY; BLOOD PRESSURE; BODY WEIGHT; CONTROLLED STUDY; DIET RESTRICTION; ENDOPLASMIC RETICULUM STRESS; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL HYPERTENSION; FOOD INTAKE; GLOMERULAR STRUCTURE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; GOTO KAKIZAKI RAT; HEART RATE; HISTOLOGY; IMMUNOHISTOCHEMISTRY; INSULIN BLOOD LEVEL; KIDNEY ARTERY; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; KIDNEY INJURY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; TRANSMISSION ELECTRON MICROSCOPY; URINE BIOCHEMISTRY; URINE SAMPLING; WESTERN BLOTTING; WISTAR RAT; ANIMAL; COMPLICATION; HYPERTENSION; KIDNEY; PATHOPHYSIOLOGY; PHYSIOLOGY; RENAL INSUFFICIENCY, CHRONIC;

ANIMALS; BLOOD GLUCOSE; BLOOD PRESSURE; DIABETES MELLITUS, TYPE 2; ENDOPLASMIC RETICULUM STRESS; HYPERTENSION; KIDNEY; MALE; OXIDATIVE STRESS; RATS; RATS, WISTAR; RENAL INSUFFICIENCY, CHRONIC;

EID: 85016112413     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.116.08560     Document Type: Article

References (56)

1. Sowers JR, Epstein M, Diabetes mellitus and associated hypertension, vascular disease, and nephropathy. An update. Hypertension 1995 26 6 pt 1 869-879
2. Van Buren PN, Toto R, Hypertension in diabetic nephropathy: epidemiology, mechanisms, and management. Adv Chronic Kidney Dis 2011 18 28-41. doi: 10.1053/j.ackd.2010.10.003.
3. Van Buren PN, Toto R, Current update in the management of diabetic nephropathy. Curr Diabetes Rev 2013 9 62-77
4. Skov J, Christiansen JS, Poulsen PL, Hypertension and diabetic nephropathy. Endocr Dev 2016 31 97-107. doi: 10.1159/000439393.
5. Khan SS, Quaggin SE, Therapies on the horizon for diabetic kidney disease. Curr Diab Rep 2015 15 111. doi: 10.1007/s11892-015-0685-3.
6. Vora JP, Ibrahim HA, Bakris GL, Responding to the challenge of diabetic nephropathy: the historic evolution of detection, prevention and management. J Hum Hypertens 2000 14 667-685
7. Berlowitz DR, Ash AS, Hickey EC, Glickman M, Friedman R, Kader B, Hypertension management in patients with diabetes: the need for more aggressive therapy. Diabetes Care 2003 26 355-359
8. Mancia G, Effects of intensive blood pressure control in the management of patients with type 2 diabetes mellitus in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Circulation 2010 122 847-849. doi: 10.1161/CIRCULATIONAHA.110.960120.
9. Roberts SS, Hypertension. Management in adults with diabetes. Diabetes Forecast 2004 57 41-42
10. Arauz-Pacheco C, Parrott MA, Raskin P, American Diabetes Association Hypertension management in adults with diabetes. Diabetes Care 2004 27 suppl 1 S65-S67
11. Retnakaran R, Cull CA, Thorne KI, Adler AI, Holman RR, UKPDS Study Group Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74. Diabetes 2006 55 1832-1839. doi: 10.2337/db05-1620.
12. Molitch ME, DeFronzo RA, Franz MJ, Keane WF, Mogensen CE, Parving HH, Steffes MW, American Diabetes Association Nephropathy in diabetes. Diabetes Care 2004 27 suppl 1 S79-S83
13. Béroniade VC, Lefebvre R, Falardeau P, Unilateral nodular diabetic glomerulosclerosis: recurrence of an experiment of nature. Am J Nephrol 1987 7 55-59
14. Berkman J, Rifkin H, Unilateral nodular diabetic glomerulosclerosis (Kimmelstiel-Wilson): report of a case. Metabolism 1973 22 715-722
15. Betz B, Conway BR, An update on the use of animal models in diabetic nephropathy research. Curr Diab Rep 2016 16 18. doi: 10.1007/s11892-015-0706-2.
16. Malhotra JD, Kaufman RJ, Endoplasmic reticulum stress and oxidative stress: a vicious cycle or a double-edged sword? Antioxid Redox Signal 2007 9 2277-2293. doi: 10.1089/ars.2007.1782.
17. Lindenmeyer MT, Rastaldi MP, Ikehata M, Neusser MA, Kretzler M, Cohen CD, Schlöndorff D, Proteinuria and hyperglycemia induce endoplasmic reticulum stress. J Am Soc Nephrol 2008 19 2225-2236. doi: 10.1681/ASN.2007121313.
18. Sheikh-Ali M, Sultan S, Alamir AR, Haas MJ, Mooradian AD, Hyperglycemia-induced endoplasmic reticulum stress in endothelial cells. Nutrition 2010 26 1146-1150. doi: 10.1016/j.nut.2009.08.019.
19. Zhong Y, Li J, Chen Y, Wang JJ, Ratan R, Zhang SX, Activation of endoplasmic reticulum stress by hyperglycemia is essential for Müller cell-derived inflammatory cytokine production in diabetes. Diabetes 2012 61 492-504. doi: 10.2337/db11-0315.
20. Ozcan L, Tabas I, Role of endoplasmic reticulum stress in metabolic disease and other disorders. Annu Rev Med 2012 63 317-328. doi: 10.1146/annurev-med-043010-144749.
21. Colle E, Guttmann RD, Seemayer T, Spontaneous diabetes mellitus syndrome in the rat. I. Association with the major histocompatibility complex. J Exp Med 1981 154 1237-1242
22. Howard CF Jr, Palotay JL, Spontaneous diabetes mellitus in Macaca cyclopis and Mandrillus leucophaeus: case reports. Lab Anim Sci 1975 25 191-196
23. Goto Y, Suzuki K, Ono T, Sasaki M, Toyota T, Development of diabetes in the non-obese NIDDM rat (GK rat). Adv Exp Med Biol 1988 246 29-31
24. Janssen U, Vassiliadou A, Riley SG, Phillips AO, Floege J, The quest for a model of type II diabetes with nephropathy: the Goto Kakizaki rat. J Nephrol 2004 17 769-773
25. Janssen U, Riley SG, Vassiliadou A, Floege J, Phillips AO, Hypertension superimposed on type II diabetes in Goto Kakizaki rats induces progressive nephropathy. Kidney Int 2003 63 2162 2170. doi: 10.1046/j.1523-1755.2003.00007.x.
26. Malo A, Krüger B, Seyhun E, Schäfer C, Hoffmann RT, Göke B, Kubisch CH, Tauroursodeoxycholic acid reduces endoplasmic reticulum stress, trypsin activation, and acinar cell apoptosis while increasing secretion in rat pancreatic acini. Am J Physiol Gastrointest Liver Physiol 2010 299 G877-G886. doi: 10.1152/ajpgi.00423.2009.
27. Pusl T, Vennegeerts T, Wimmer R, Denk GU, Beuers U, Rust C, Tauroursodeoxycholic acid reduces bile acid-induced apoptosis by modulation of AP-1. Biochem Biophys Res Commun 2008 367 208-212. doi: 10.1016/j.bbrc.2007.12.122.
28. Rodrigues CM, Sola S, Nan Z, Castro RE, Ribeiro PS, Low WC, Steer CJ, Tauroursodeoxycholic acid reduces apoptosis and protects against neurological injury after acute hemorrhagic stroke in rats. Proc Natl Acad Sci U S A 2003 100 6087-6092. doi: 10.1073/pnas.1031632100.
29. do Carmo JM, Bassi M, da Silva AA, Hall JE, Systemic but not central nervous system nitric oxide synthase inhibition exacerbates the hypertensive effects of chronic melanocortin-3/4 receptor activation. Hypertension 2011 57 428-434. doi: 10.1161/HYPERTENSIONAHA.110.163931.
30. Hinojosa-Laborde C, Jespersen B, Shade R, Physiology lab demonstration: Glomerular filtration rate in a rat. J Vis Exp 2015 e52425
31. Dworkin LD, Feiner HD, Randazzo J, Glomerular hypertension and injury in desoxycorticosterone-salt rats on antihypertensive therapy. Kidney Int 1987 31 718-724
32. Kojima N, Slaughter TN, Paige A, Kato S, Roman RJ, Williams JM, Comparison of the development diabetic induced renal disease in strains of goto-kakizaki rats. J Diabetes Metab 2013 suppl 9: S9-005
33. Pagtalunan ME, Miller PL, Jumping-Eagle S, Nelson RG, Myers BD, Rennke HG, Coplon NS, Sun L, Meyer TW, Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest 1997 99 342 348. doi: 10.1172/JCI119163.
34. Cheng ZJ, Vaskonen T, Tikkanen I, Nurminen K, Ruskoaho H, Vapaatalo H, Muller D, Park JK, Luft FC, Mervaala EM, Endothelial dysfunction and salt-sensitive hypertension in spontaneously diabetic Goto-Kakizaki rats. Hypertension 2001 37 2 pt 2 433-439
35. Bertocchio JP, Warnock DG, Jaisser F, Mineralocorticoid receptor activation and blockade: an emerging paradigm in chronic kidney disease. Kidney Int 2011 79 1051-1060. doi: 10.1038/ki.2011.48.
36. Shibata S, Fujita T, Mineralocorticoid receptors in the pathophysiology of chronic kidney diseases and the metabolic syndrome. Mol Cell Endocrinol 2012 350 273-280. doi: 10.1016/j.mce.2011.07.018.
37. Gagliardini E, Perico N, Rizzo P, Buelli S, Longaretti L, Perico L, Tomasoni S, Zoja C, Macconi D, Morigi M, Remuzzi G, Benigni A, Angiotensin II contributes to diabetic renal dysfunction in rodents and humans via Notch1/Snail pathway. Am J Pathol 2013 183 119-130. doi: 10.1016/j.ajpath.2013.03.025.
38. Erdely A, Freshour G, Baylis C, Resistance to renal damage by chronic nitric oxide synthase inhibition in the Wistar-Furth rat. Am J Physiol Regul Integr Comp Physiol 2006 290 R66-R72. doi: 10.1152/ajpregu.00444.2005.
39. Hoshi S, Shu Y, Yoshida F, Inagaki T, Sonoda J, Watanabe T, Nomoto K, Nagata M, Podocyte injury promotes progressive nephropathy in zucker diabetic fatty rats. Lab Invest 2002 82 25-35
40. Coimbra TM, Janssen U, Gröne HJ, Ostendorf T, Kunter U, Schmidt H, Brabant G, Floege J, Early events leading to renal injury in obese Zucker (fatty) rats with type II diabetes. Kidney Int 2000 57 167-182. doi: 10.1046/j.1523-1755.2000.00836.x.
41. Tesch GH, Lim AK, Recent insights into diabetic renal injury from the db/db mouse model of type 2 diabetic nephropathy. Am J Physiol Renal Physiol 2011 300 F301-F310. doi: 10.1152/ajprenal.00607.2010.
42. Pourghasem M, Nasiri E, Shafi H, Early renal histological changes in alloxan-induced diabetic rats. Int J Mol Cell Med 2014 3 11-15
43. Kanwar YS, Sun L, Xie P, Liu FY, Chen S, A glimpse of various pathogenetic mechanisms of diabetic nephropathy. Annu Rev Pathol 2011 6 395-423. doi: 10.1146/annurev.pathol.4.110807.092150.
44. Forbes JM, Cooper ME, Mechanisms of diabetic complications. Physiol Rev 2013 93 137-188. doi: 10.1152/physrev.00045.2011.
45. Schena FP, Gesualdo L, Pathogenetic mechanisms of diabetic nephropathy. J Am Soc Nephrol 2005 16 suppl 1 S30-S33
46. Woods LL, Mizelle HL, Hall JE, Control of renal hemodynamics in hyperglycemia: possible role of tubuloglomerular feedback. Am J Physiol 1987 252 1 pt 2 F65-F73
47. Carlström M, Wilcox CS, Arendshorst WJ, Renal autoregulation in health and disease. Physiol Rev 2015 95 405-511. doi: 10.1152/physrev.00042.2012.
48. Vallon V, Komers R, Pathophysiology of the diabetic kidney. Compr Physiol 2011 1 1175-1232. doi: 10.1002/cphy.c100049.
49. Maric C, Hall JE, Obesity, metabolic syndrome and diabetic nephropathy. Contrib Nephrol 2011 170 28 35. doi: 10.1159/000324941.
50. Gnudi L, Thomas SM, Viberti G, Mechanical forces in diabetic kidney disease: a trigger for impaired glucose metabolism. J Am Soc Nephrol 2007 18 2226-2232. doi: 10.1681/ASN.2006121362.
51. Ozcan U, Yilmaz E, Ozcan L, Furuhashi M, Vaillancourt E, Smith RO, Görgün CZ, Hotamisligil GS, Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science 2006 313 1137-1140. doi: 10.1126/science.1128294.
52. Csordás G, Hajnóczky G, SR/ER-mitochondrial local communication: calcium and ROS. Biochim Biophys Acta 2009 1787 1352-1362. doi: 10.1016/j.bbabio.2009.06.004.
53. Pacher P, Sharma K, Csordás G, Zhu Y, Hajnóczky G, Uncoupling of ER-mitochondrial calcium communication by transforming growth factor-beta. Am J Physiol Renal Physiol 2008 295 F1303-F1312. doi: 10.1152/ajprenal.90343.2008.
54. Aghdam SY, Sheibani N, The ubiquitin-proteasome system and microvascular complications of diabetes. J Ophthalmic Vis Res 2013 8 244-256
55. Cunard R, Endoplasmic reticulum stress in the diabetic kidney, the good, the bad and the ugly. J Clin Med 2015 4 715-740. doi: 10.3390/jcm4040715.
56. Cunard R, Sharma K, The endoplasmic reticulum stress response and diabetic kidney disease. Am J Physiol Renal Physiol 2011 300 F1054-F1061. doi: 10.1152/ajprenal.00021.2011.